Printer Friendly
The Free Library
19,255,778 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Artimplant AB Interim Report January 1 - March 31, 2006.


STOCKHOLM, Sweden -- Artimplant AB (STO:ARTIB):

--Net revenue amounted SEK SEK

In currencies, this is the abbreviation for the Swedish Krona.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 1.1 million (1.1)

--Net profit of SEK -10.4 million (-9.1)

--Earnings per share of SEK -0.17 (SEK -0.23)

--Artelon(R) implant for rotator cuff reinforcement received clearance for marketing in the US and was launched by Biomet at AAOS AAOS American Academy of Orthopaedic Surgeons.
AAOS American Academy of Orthopaedic Surgery
 in Chicago

--Increased number of clinics using Artelon(R) products increased the underlying product sales run rate in the US and in Scandinavia

--Artelon(R) DRU DRU Druid (Everquest)
DRU Disaster Resistant University
DRU Direct Reporting Unit
DRU Dansk Rugby Union (Danish Rugby Club)
DRU Dynamic Reference Unit
DRU Data Recovery Unit
DRU Data Retrieval Unit
 Spacer received CE-mark

--Artelon(R) TMC Spacer cleared for marketing in Canada

Events after the period

--Tord Lendau resigns as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  for private reasons

About Artimplant

Artimplant is a biomaterials company focused on solutions to problems in orthopedic, odontological and reconstructive surgery. The Company is engaged in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The proprietary technology Artelon(R), a long-term degradable biomaterial, offers new solutions to unmet clinical needs and opens new markets. Artimplant's business model is that of licensing its products and technology to global partners. The Company currently has six licensing agreements and one distribution agreement with three global partners. Artimplant is a public company, listed on the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. , O-list.

Forward-looking statements

This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence ob·so·les·cent  
adj.
1. Being in the process of passing out of use or usefulness; becoming obsolete.

2. Biology Gradually disappearing; imperfectly or only slightly developed.
; general economic conditions; and other risks detailed from time to time in the Company's filings.

This information was brought to you by Waymaker http://www.waymaker.net
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 3, 2006
Words:311
Previous Article:New Asset Allocation Suite Helps Financial Professionals Save Time & Build Client Loyalty; Programs from the Principal Address Common Investor Error.
Next Article:NovaStar Closes $1.35 Billion Asset Backed Securitization.



Related Articles
Artimplant: Nine-month report 2000.
Artimplant Interim Report January 1 - June 30, 2001.
Artimplant Ab Annual Accounts Jan 1 - DEC 31, 2005.
OMRON Announces Increased Dividend Forecast for Fiscal Year ending March 31, 2006.
CyberAgent Announcement Regarding Interim Performance Forecasts.
Artimplant Appoints Lars-Johan Cederbrant as Interim CEO.
Information Published by RaySearch Laboratories AB (publ) from January 1, 2005 through June 19, 2006.
Artimplant: Presentation of Artimplant's Interim Report January - June 2006 on August 8, 2006.
Artimplant: Invitation to Artimplant's Capital Market Day on November 16, 2006.
ORIX Announces Interim (April 1-September 30) Net Income Up 9% Year on Year to 91.3 Billion Yen.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles